Top Markets
#1 ADO Protocol ADO Protocol +329.10%
#2 GoPlus Security GoPlus Security +53.44%
#3 Nockchain Nockchain +43.26%
#4 Starpower Starpower +34.71%
#5 Tutorial Tutorial +34.36%
#6 The Black Bull The Black Bull +33.14%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +32.41%
#8 GAIB AID GAIB AID +24.67%
#9 Verus Coin Verus Coin +20.40%
#10 Fake World Assets Fake World Assets +18.95%
Coin of the day
ADO Protocol ADO Protocol
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
Rang in Aktien #32813
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
Aktienkurs
$2.22
Marktkapitalisierung
$9.03M
Veränderung (1 Tag)
-3.13%
Veränderung (1 Jahr)
-21.92%
Land
JP
Handel PhoenixBio Co., Ltd. (6190)

Kategorie

Healthcare
Kursverlauf für PhoenixBio Co., Ltd. (6190)
Höchster Schlusskurs: $2.26 am 2026-08-01

Niedrigster Schlusskurs: $22.51 am 2016-03-01
Kursverlauf der Aktie von PhoenixBio Co., Ltd. von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -11.29%
2025 45.96%
2024 -30.54%
2023 -37.47%
2022 10.54%
2021 -19.56%
2020 -25.90%
2019 13.30%
2018 -31.36%
2017 -30.45%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.56 31.25%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $990.64 51.51%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 7.19%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 13.38%
BE